Review article: the treatment of Helicobacter pylori infection
- 1 June 1992
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 6 (3) , 291-303
- https://doi.org/10.1111/j.1365-2036.1992.tb00051.x
Abstract
The discovery of Helicobacter pylori has stimulated great interest in its role in gastritis, non-ulcer dyspepsia and peptic ulceration. Treatment regimens to eradicate this organism from gastric mucosa have also received considerable attention. Current recommendations limit the use of triple drug combinations only to specific patient groups.Keywords
This publication has 52 references indexed in Scilit:
- Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia.BMJ, 1991
- Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study.Gut, 1990
- OMEPRAZOLE, HELICOBACTER PYLORI, GASTRITIS, AND DUODENAL ULCERThe Lancet, 1989
- Prevalence of Helicobacter pylori Infection and Histologic Gastritis in Asymptomatic PersonsNew England Journal of Medicine, 1989
- OMEPRAZOLE, CAMPYLOBACTER PYLORI, AND DUODENAL ULCERThe Lancet, 1989
- Use of endoscopy in patients with dyspepsia.BMJ, 1989
- Campylobacter pyloriin Peptic Ulcer Disease: III. Symptoms and Paraclinical and Epidemiologic FindingsScandinavian Journal of Gastroenterology, 1988
- Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.Gut, 1986
- RELAPSE RATES IN DUODENAL ULCER PATIENTS FORMERLY TREATED WITH BISMUTH SUBCITRATE OR MAINTAINED WITH CIMETIDINEThe Lancet, 1984
- DIFFERENCE IN RELAPSE RATES OF DUODENAL ULCER AFTER HEALING WITH CIMETIDINE OR TRIPOTASSIUM DICITRATO BISMUTHATEThe Lancet, 1981